Learn More
BACKGROUND Conventional patent-based drug development incentives work badly for the developing world, where commercial markets are usually small to non-existent. For this reason, the past decade has seen extensive experimentation with alternative R&D institutions ranging from private-public partnerships to development prizes. Despite extensive discussion,(More)
a organisms in bold are included in the World Health organization (Geneva) Tropical disease portfolio. b Number of transcripts in each genome. c Number of targets with at least one domain accurately modeled (that is, ModPIPE quality score of at least 1.0). d Number of modeled targets with at least one predicted binding site for a molecule with a Tanimoto(More)
  • 1